T&R Biofab Co., Ltd. (KOSDAQ:246710)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,030.00
+150.00 (5.21%)
Aug 8, 2025, 3:30 PM KST
5.21%
Market Cap62.05B
Revenue (ttm)9.64B
Net Income (ttm)-5.32B
Shares Out21.55M
EPS (ttm)-246.20
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,220,100
Average Volume272,126
Open2,915.00
Previous Close2,880.00
Day's Range2,915.00 - 3,740.00
52-Week Range2,750.00 - 7,900.00
Beta0.87
RSI19.37
Earnings DateAug 22, 2025

About Verve Therapeutics

T&R Biofab Co., Ltd. develops and commercializes various regenerative medical technologies. It offers 3D-printed medical devices; and bio-surgical solutions, which includes wound dressing and acellular dermal matrix, as well as biomaterials and biopharmaceuticals. The company was founded in 2013 and is based in Siheung-si, South Korea. [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 2013
Employees 93
Stock Exchange KOSDAQ
Ticker Symbol 246710
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.